Rheumatoid Arthritis

In Rheumatoid Arthritis (RA), the most common chronic inflammatory joint disease, autoantibodies attack the joints and cause joint destruction. Below are COVID news and research updates that specifically relate to RA.

Long COVID & Systemic Autoimmune Rheumatic Diseases

Those suffering from systemic autoimmune rheumatic diseases have an increased risk of severe outcomes from a COVID-19 infection. Due to factors such as altered immunity or the use of immunosuppressive medications, they may also be at risk of developing Long COVID.

Read More »

COVID-19 Outcomes in Myasthenia Gravis Patients

Symptoms related to COVID-19 infections such as systemic inflammation, neurological complications, and a dysregulated immune response can lead to worse clinical outcomes for patients with Myasthenia Gravis (MG). Researchers conducted an observational retrospective study to measure COVID-19 outcomes in these patients, especially in regard to exacerbation of MG symptoms.

Read More »

SLE Flares Post COVID-19 Vaccine

A study in Japan analyzed the association between mRNA Covid-19 vaccination and medium-term SLE flare-ups. At 30 days after completion of a primary series, the rate of mild or moderate SLE flares was 20.3% within the vaccinated group, versus 23.3% in the unvaccinated group. Flare rates at 60 and 90 days were similar between both groups. 

Read More »
Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.

By adding your phone number, you agree to receive text message updates. Msg & data rates may apply.